- Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
- Celularity Inc. to Host Investor and Analyst Research & Development Day
- Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
Key statistics
On Wednesday, Celularity Inc (CELU:NAQ) closed at 3.04, 91.19% above the 52 week low of 1.59 set on Dec 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.20 |
---|---|
High | 3.27 |
Low | 3.01 |
Bid | 1.24 |
Offer | 3.27 |
Previous close | 3.11 |
Average volume | 22.50k |
---|---|
Shares outstanding | 21.78m |
Free float | 10.68m |
P/E (TTM) | -- |
Market cap | 66.22m USD |
EPS (TTM) | -10.51 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 17:59 BST.
More ▼